Alberto Puig Canto

Alberto Puig Canto has extensive experience in the scientific and healthcare fields. Alberto is currently working as a Scientific Director at Envision Pharma Group since October 2019. Prior to this, from 2017 to 2019, they held the position of Scientific Director at Axiom Healthcare Strategies, where they also served as the Director of Competitive Strategy from 2017 to 2019. From 2013 to 2017, Alberto worked at DAVA Oncology, first as a Research Associate and later as a Manager. Alberto began their career as a Research Assistant at UT Southwestern Medical Center at Dallas from 2007 to 2012, where they made significant contributions to the field of monoclonal antibody engineering. Alberto also gained experience as an intern at the Institute of Food Research in 2007. Alberto's educational background includes being a former student at Universidad de Alicante from 2004 to 2006.

Alberto Puig Canto completed their education at the Universitat d'Alacant. From 1998 to 2004, they pursued a Bachelor's degree in Biology/Biological Sciences, General. Following this, they furthered their education by completing a Master of Science degree in Biotechnology from 2004 to 2006 at the same institution.